Summary & Overview
HCPCS P9027: Red Blood Cells, Leukocyte Reduced, O2/CO2 Reduced, Per Unit
HCPCS Level II code P9027 designates a processed red blood cell unit that is leukocyte reduced and has reduced oxygen and carbon dioxide levels. This code identifies a specific blood product variant used in transfusion medicine for patients who require modified red blood cell units due to clinical considerations such as immunologic risk or gas-content management. Nationally, accurate coding of specialized blood components affects clinical documentation, billing consistency, and supply-chain tracking for hospitals and transfusion services.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of the clinical context for these processed red blood cells, typical sites of service where the product is used, and the payer landscape relevant to claims for specialized blood products. The publication also outlines benchmarking and billing patterns where available, policy considerations affecting coverage and coding, and operational notes for hospital blood banks and transfusion services. Where input data is not provided, the text notes that information is unavailable.
Billing Code Overview
HCPCS Level II code P9027 describes red blood cells, leukocytes reduced, oxygen/carbon dioxide reduced, each unit. The service represents the provision of blood products specifically processed to reduce leukocyte content and to alter oxygen and carbon dioxide levels for transfusion. The service type is blood product transfusion/processed blood component supply. The typical site of service is inpatient or outpatient hospital transfusion setting, including hospital blood banks and transfusion centers.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with symptomatic anemia secondary to chronic disease or prior blood loss is admitted for transfusion support. The clinical indication is to increase oxygen-carrying capacity while minimizing transfusion reactions and alloimmunization. The blood bank provides units labeled P9027 (red blood cells, leukocytes reduced, oxygen/carbon dioxide reduced) for transfusion. Typical workflow: order entry by the treating physician with an indication and transfusion consent; pre-transfusion testing (type and screen, antibody screen); blood bank selection and crossmatch; product preparation and verification of P9027 units; nursing bedside verification of patient identity and product details; transfusion administration with vital sign monitoring and documentation; post-transfusion assessment and hemoglobin check. Typical sites of service include inpatient hospital wards, observation units, emergency departments, and outpatient infusion centers that perform blood transfusions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Normal processing | When no modifier applies; standard reporting of the service |